2021
A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS.
Amyotrophic lateral sclerosis & frontotemporal degeneration
鈥�Research at a glance
Top areas of exploration
- Myasthenia Gravis , 8 publications
- Amyotrophic Lateral Sclerosis , 5 publications
- Prednisone , 5 publications
- Receptors, Cholinergic , 4 publications
Research activity
My publications
Filter publications
20 publications
2021
Individualizing Therapy in CIDP: A Mini-Review Comparing the Pharmacokinetics of Ig With SCIg and IVIg.
Frontiers in neurology
鈥�2021
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS): Bayesian Adaptive Comparative Effectiveness Randomized Trial.
JAMA neurology
鈥�2020
Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial.
JAMA neurology
鈥�2020
Minimal manifestation status and prednisone withdrawal in the MGTX trial.
Neurology
鈥�